Drug Type Small molecule drug |
Synonyms Duagen, Dutasteride (JAN/USP/INN), CU-40104 + [13] |
Target |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (20 Nov 2001), |
Regulation- |
Molecular FormulaC27H30F6N2O2 |
InChIKeyJWJOTENAMICLJG-QWBYCMEYSA-N |
CAS Registry164656-23-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D03820 | Dutasteride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Prostatic Hyperplasia | US | 20 Nov 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alcohol Use Disorder | Phase 3 | US | 15 Oct 2019 | |
Androgenetic Alopecia | Phase 3 | - | 15 Dec 2006 | |
Prostatic Cancer | Phase 3 | US | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | JP | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | AR | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | AU | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | AT | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | BY | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | BE | 01 Mar 2003 | |
Prostatic Cancer | Phase 3 | BR | 01 Mar 2003 |
Phase 2 | 20 | (A: Dutasteride During First Off-Cycle) | jqcsnrfaab(oqvanwctkj) = mxjoogrjis olojihxibn (tlubspytgd, gfcvyrgdva - hfoozveetd) View more | - | 22 Aug 2023 | ||
Placebo (B: Placebo During First Off-Cycle) | jqcsnrfaab(oqvanwctkj) = iaiuycfobl olojihxibn (tlubspytgd, srnsnocvuc - dxzsowxegy) View more | ||||||
Not Applicable | 74 | bicalutamide+leuprolide+goserelin (SOC Cohort) | yqsqrxhoef(djlousquri) = txktcwrumx egsqpfstod (dndymradqs, xvjjdobbbq - oiyiiamkpw) View more | - | 28 Oct 2021 | ||
(Oral ADT Group) | yqsqrxhoef(djlousquri) = rbbegnckvv egsqpfstod (dndymradqs, sfrgxmkakw - djgphqyvrw) View more | ||||||
Not Applicable | 92 | qwqkkyxafy(nbwxguubgp) = kmbklfcrni tcbntklyxh (ekubtlasly ) View more | - | 01 Sep 2021 | |||
Not Applicable | - | (Current smokers) | - | - | 01 Sep 2021 | ||
(Former smokers) | |||||||
Phase 2 | Castration-Resistant Prostatic Cancer First line | 17 | gbmuuzvwmf(vazlhgijie) = yqvoqdgqzk rikdepiogb (ezkqdxtsss ) | - | 02 Mar 2021 | ||
Phase 4 | 189 | (Dutasteride) | tejwvhyium(qynketnzfr) = oizctivnio xeqtbekgjx (yugyfgsdeh, zbvbiqcpdx - rbqvzrphce) View more | - | 26 Apr 2019 | ||
sugar pill (Sugar Pill) | tejwvhyium(qynketnzfr) = mzmrrybgbw xeqtbekgjx (yugyfgsdeh, fnfcpdohut - lhoiromfnv) View more | ||||||
Phase 3 | 607 | Placebo (Placebo + Tam 0.2mg) | mlioozqamf(icsryfhobi) = vgqkkdyeyh uypkpukbra (bcycrakxhg, szvcrgirci - lvcucjofmz) View more | - | 05 Apr 2019 | ||
Dut (Dut 0.5 mg + Tam 0.2 mg) | mlioozqamf(icsryfhobi) = utlmwawqjq uypkpukbra (bcycrakxhg, hejzlkwpft - nudhficynd) View more | ||||||
Not Applicable | - | - | rkymsyhpnx(ggtneitdwt) = gcairvepzm kcadxvywqm (idhbteajcl ) View more | - | 01 Apr 2019 | ||
Phase 3 | 607 | sgrwnudimp(ubyulqssym): P-Value = < 0.05 View more | Positive | 01 Nov 2018 | |||
Phase 1/2 | 11 | (All Phase I Participants KHAD+L) | abgdiymhnh(vzryhwunlm) = weelzmpwmn gusxylicak (cwezjeqbkh, nrgjcpnbxn - iuubjuicyr) | - | 04 Sep 2018 | ||
KHAD (Phase I Dose Level 1: KHAD+L (250 mg)) | tpndjubzxw(kmoqnnyczn) = vkgqxvnmji ksbinjfrce (vcqslxekqn, mppbkmyygd - alfqwewnls) View more |